Header Journal IJCC
Kembali ke Rincian Terbitan Efficacy of gefitinib versus erlotinib as first-line treatment in EGFR mutant advanced lung adenocarcinoma at RSP Dr. H. A. Rotinsulu Unduh Unduh PDF